Poland· PL-100252916
Trajenta
A linagliptin product containing linagliptinum, registered in Poland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Linagliptin is registered in 17 of 19 countries.
Countries holding a registration under ATC A10BH05 (linagliptin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Linagliptin · ATC A10BH05
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of linagliptin costs, country by country.
Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Linagliptin · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- IT Italy$2.52
- CH Switzerland$2.05
The record
At a glance
URPL (Poland)- Active substance
- Linagliptinum
- Manufacturer
- Boehringer Ingelheim International GmbH
- Country
- Poland (PL)
- ATC code
- A10BH05
- ATC class
- Linagliptin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 11
- gtin05909990896097
- gtin05909990896158
- gtin05909990896165
- gtin05909990896172
- gtin05909990896189
- gtin05909990896196
- gtin05909990896202
- gtin05909990896233
- gtin05909990896080
- gtin05909990896103
- gtin05909990896141
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
373 interactions on record for linagliptin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Linagliptin · interactions on record
373 records
- 3 severe
- 330 moderate
- 40 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Linagliptin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGLUNAVAMedochemie Ltd., Limassol
- SpainDONUMID 5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGLaboratorios Alter S.A.
- SwedenDrojarto 5 mg Filmdragerad tablettDemo S.A.
- SwitzerlandLinagliptin NOBEL 5mg, FilmtablettenNOBEL Pharma Schweiz AG
- NetherlandsLinagliptine Abdi 5 mg filmomhulde tablettenAbdi Farma GmbH
- FinlandLinagliptin AccordAccord Healthcare B.V.
- IrelandLinagliptin Accord 5 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- IcelandAnsfiedAdalvo Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ilinpru, Liamell
- Belgium · Linagliptin Eg, Linagliptin Eg (Eurogenerics) Nv
- Bulgaria · Linagliptin Accord, Глунава
- Cyprus · Glunava, Linagliptin Accord
- Czechia · Glunava, Jeligo
- Germany · Linagliptin Abdi
- Denmark · Linagliptin "pharmapath", Linagliptin Accord
- Estonia · Glunava, Linagliptin Accord
- Spain · Donumid, Ilinpru
- Finland · Linagliptin Accord, Linagliptin Advanz Pharma
- France · Linagliptine Zentiva
- United Kingdom (Northern Ireland) · Linagliptin, Linagliptin Altair Science
- Greece · Bottiar, Drojarto
- Croatia · Larida, Liglinra
- Hungary · Ilinpru, Jeligo
- Ireland · Linagliptin Accord, Linagliptin Clonmel
- Iceland · Linagliptin Krka, Linagliptin Stada
- Italy · Linagliptin Abdi, Linagliptin Aurobindo
- Liechtenstein · Trajenta
- Lithuania · Bottiar, Jeligo
- Luxembourg · Linagliptin Eg
- Latvia · Linagliptin Accord, Linagliptin Olpha
- Malta · Liamell, Linagliptin
- Netherlands · Linagliptin Viatris, Linagliptin Vivanta
- Norway · Linagliptin Accord, Linagliptin Krka
- Portugal · Enanta, Larida
- Romania · Jeligo, Linagliptin Medochemie
- Sweden · Liglinra, Linagliptin Accord
- Slovenia · Liglipex, Linagliptin Krka
- Slovakia · Glunava, Ilinpru
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d8aa414f-2258-4abc-a96c-52217dcb472d GET /v1/drugs/d8aa414f-2258-4abc-a96c-52217dcb472d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909990896103 ¦ Rp ¦ EU/1/11/707/003 ¦ 67298\n28 tabl.\n05909990896141 ¦ Rp ¦ EU/1/11/707/004 ¦ 68592\n30 tabl.\n05909990896080 ¦ Rp ¦ EU/1/11/707/001 ¦ 68677\n10 tabl.\n05909990896097 ¦ Rp ¦ EU/1/11/707/002 ¦ 68678\n14 tabl.\n05909990896158 ¦ Rp ¦ EU/1/11/707/005 ¦ 68688\n56 tabl.\n05909990896165 ¦ Rp ¦ EU/1/11/707/006 ¦ 68806\n60 tabl.\n05909990896172 ¦ Rp ¦ EU/1/11/707/007 ¦ 68807\n84 tabl.\n05909990896189 ¦ Rp ¦ EU/1/11/707/008 ¦ 68808\n90 tabl.\n05909990896196 ¦ Rp ¦ EU/1/11/707/009 ¦ 68809\n98 tabl.\n05909990896202 ¦ Rp ¦ EU/1/11/707/010 ¦ 68810\n100 tabl.\n05909990896233 ¦ Rp ¦ EU/1/11/707/011 ¦ 68811\n120 tabl.",
"substance": "Linagliptin 5 mg",
"common_name": "Linagliptinum",
"pl_product_id": "100252916",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about linagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.